Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic
  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Week in Review: Sorrento Acquires ACEA in $488 Million Deal between Two San Diego-China Oncology Biopharmas

Deals and Financings   Sorrento Therapeutics will acquire ACEA Therapeutics in a deal worth up to $488 million; both companies are San Diego-China oncology biopharmas; Long Hill Capital, a  China  healthcare venture firm, closed its third fund with more than $300 million in committed capital; Hutchison China MediTech raised $100 million in a private placement with Baring Private Equity Asia for its ten oncology assets; NewMed Medical Company of  Shanghai  closed a $100 million Series C round led by  Singapore 's Temasek for minimally invasive heart disease devices; Biogen, a  Cambridge ,  MA  biopharma, in-licensed ex-China rights to a biosimilar aimed at rheumatoid arthritis from  Guangzhou 's Bio-Thera; HitGen of Chengdu identified novel small-molecule compounds for a high-value biological target in a collaboration with San Francisco 's BioAge Labs;  Trials and Approvals   Beijing 's BeiGene was approved to manufacture the company's marketed anti-PD-1 antibody at its new one million square feet  Guangzhou  facility; Shanghai 's I-Mab dosed the first patient in a US Phase I trial of a novel bispecific antibody in patients with advanced or metastatic solid tumors; Bridge Biotherapeutics, a Korea - China - US company, started a Phase I/II trial of a novel EGFR inhibitor in NSCLC patients with a specific mutation; Shanghai Antengene will start a China Phase I clinical trial of a dual inhibitor in patients with advanced solid tumors or non-Hodgkin's lymphoma;  Industry News   Invesco launched a new China Healthcare Equity fund that offers a diversified portfolio of China-listed healthcare companies.  Stock Symbols: (NSDQ: SRNE) (NSDQ: BIIB) (SHA: 688177) (SHA: 688222) (NSDQ: BGNE; HK: 06160) (NSDQ: IMAB) (KOSDAQ: 288330) (HK: 6996)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.